US EditionUS FDA Approves New Generic Abortion Pill, Prompting Backlash From Conservatives
The FDA's approval of a new generic mifepristone pill faces pro-life backlash amid concerns over safety and expanded access, with abortion pills accounting for 63% of U.S. abortions.
- On Tuesday, the U.S. Food & Drug Administration approved a new generic mifepristone during the Trump administration's term.
- Because generic approvals require matching the original drug, the FDA approved Evita Solutions LLC's application filed four years ago under the generic drug approval process .
- On social media, critics and supporters reacted, with Mini Timmaraju of Reproductive Freedom for All saying `This is exactly how our system is supposed to work, and it has worked this way for decades` while various conservative leaders and social media commentators voiced sharp criticism.
- Students for Life Action sent a letter to Health Secretary Robert F. Kennedy Jr. and FDA Commissioner Dr. Marty Makary and filed a FIFTH citizen petition demanding a real review.
- Advocates warn mail-order distribution of abortion pills circumvents state laws and cite that chemical abortion pills account for 63% of U.S. abortions with an 11% severe-event rate.
24 Articles
24 Articles
Federal officials approved another rich version of the mifepristone abortive gland, causing rejection of conservatives.
Washington, Oct 2 (EFE).- The U.S. Food and Drug Administration (FDA) approved on Thursday a new generic version of the abortion pill mifepristone, one of two drugs used in abortion with medication up to ten weeks of pregnancy. Evita Solutions received authorization to market its product, becoming the second pharmaceutical with an approved generic of this medicine, along with GenBioPro. “When an equivalence application meets the requirements of …
U.S. regulators approved a new generic version of the mifepristone abortion pill, sparking protests from conservative sectors. Anti-abortion groups and personalities condemned the regulatory measure. Student for Life Action called it "a stain on the presidency of (Donald) Trump." The pharmacist Evita announced on her website that the Food and Drug Administration (FDA) approved this week its generic version of mifepristone, used to interrupt preg…
FDA approves new version of abortion pill, prompting backlash from pro-life leaders
The Trump administration is under fire from pro-life advocates after the U.S. Food and Drug Administration (FDA) quietly approved a new generic version of the abortion… The post FDA approves new version of abortion pill, prompting backlash from pro-life leaders appeared first on CatholicVote org.
The arrival of this new generic has led to the indignation of conservatives and anti-abortion associations.
Coverage Details
Bias Distribution
- 62% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
